Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioIntervene

Request full access

Developing non-addictive medicines for chronic pain and neurodegenerative disorders using selective adenosine A3 receptor agonists

San Diego, United StatesHealth

About BioIntervene

BioIntervene, Inc. is a preclinical stage biopharmaceutical company focused on discovering and developing effective, non-addictive medicines for chronic pain, chronic inflammatory, and neurodegenerative disorders. Founded in 2014, the company leverages insights from research conducted at Saint Louis University and the National Institutes of Health (NIH). BioIntervene's pioneering work centers on the biology of adenosine A3 receptors, aiming to create first-in-class, selective adenosine A3 receptor agonists.

The company operates in the biopharmaceutical market, targeting healthcare providers, researchers, and pharmaceutical companies as its primary clients. BioIntervene's business model revolves around the research and development (R&D) of novel drug candidates, which are then licensed out or sold to larger pharmaceutical companies for further development and commercialization. Revenue is generated through licensing agreements, milestone payments, and royalties from successful drug candidates.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
1.4/100
Industry
Health
Sector
Biotechnology, Hard Tech
Business model
Manufacturing

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Feb 2020 $30M $120M MPM BioImpact ↗
EARLY VCEquity / VC Mar 2019 $3.1M $12M Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

BioIntervene website traffic

Latest recorded traffic for BioIntervene is 210 monthly website visits.

Latest monthly visits210
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BioIntervene in the San Diego ecosystem

Live from Dealroom

The BioIntervene office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • MPM BioImpact
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BioIntervene on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioIntervene’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.